Aquatic Capital Management LLC Morphic Holding, Inc. Transaction History

Aquatic Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$26.64 - $40.31 $106,560 - $161,240	4,000 New	4,000 $140,000
Q3 2023 Nov 14, 2023	BUY	$21.33 - $59.42 $40,527 - $112,898	1,900 New	1,900 $44,000
Q4 2022 Feb 14, 2023	BUY	$24.14 - $30.37 $50,694 - $63,777	2,100 Added 300.0%	2,800 $75,000
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $15,561 - $23,359	700 New	700 $20,000
Q2 2022 Aug 15, 2022	SELL	$19.74 - $43.01 $9,870 - $21,505	-500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$36.25 - $52.02 $18,125 - $26,010	500 New	500 $20,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.